FOR PATIENTS WITH HEMOPHILIA B
ACHIEVE
NEW HEIGHTS
with proven, long-lasting bleed protection
ONLY IDELVION DELIVERS
*Hemophilia FIX Market Assessment. Third-Party Market Research.
†Once well‑controlled (1 month without spontaneous bleeding or requiring dose adjustments on a weekly dose of ≤40 IU/kg), people 12 years and older can be transitioned to 14-day dosing.
‡The average dose for adults and adolescents receiving prophylaxis every 7 days was 37 IU/kg.
§The median AsBR for people who started on 7- or 14-day prophylaxis was 0. For people who switched to phophylaxis from on-demand, the median AsBR was 0.7. AsBR=annualized spontaneous bleed rate.
I Choose IDELVION–Shonda
It puts my son Michael in a position to maintain control of his hemophilia B.”
I Choose IDELVION–Ray
I no longer think about needing to treat on-demand because I’m comfortable with the coverage I get.”
I Choose IDELVION–Rick
With high factor levels—and trough levels—I can enjoy time with family.”
IDELVION Connect™ offers a wide variety of resources like connecting with other patients and financial support
As a caregiver, you play a vital role in treatment, and we have information just for you
